PCM
CDMO

Palisade Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Palisade Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,962,999
Closed -$22.3M – 387
2024
Q3 		$22.3M Sell
1,962,999
-150,298
-7% -$1.51M 0.59% 67
2024
Q2 		$15.1M Sell
2,113,297
-59,535
-3% -$455K 0.41% 85
2024
Q1 		$14.6M Buy
2,172,832
+395,011
+22% +$2.72M 0.38% 92
2023
Q4 		$11.6M Buy
1,777,821
+204,981
+13% +$1.32M 0.31% 105
2023
Q3 		$14.8M Buy
1,572,840
+527,163
+50% +$6.34M 0.41% 86
2023
Q2 		$14.6M Buy
1,045,677
+43,402
+4% +$740K 0.39% 90
2023
Q1 		$18.8M Buy
1,002,275
+12,308
+1% +$202K 0.51% 69
2022
Q4 		$13.6M Buy
989,967
+46,450
+5% +$711K 0.37% 90
2022
Q3 		$18M Buy
943,517
+1,414
+0.2% +$25.8K 0.51% 64
2022
Q2 		$14.4M Buy
942,103
+83,677
+10% +$1.24M 0.39% 84
2022
Q1 		$17.5M Sell
858,426
-89,897
-9% -$1.83M 0.4% 86
2021
Q4 		$27.7M Buy
948,323
+3,678
+0.4% +$105K 0.56% 61
2021
Q3 		$20.4M Buy
944,645
+75,605
+9% +$1.83M 0.44% 78
2021
Q2 		$22.3M Sell
869,040
-7,859
-0.9% -$168K 0.5% 67
2021
Q1 		$16M Buy
+876,899
New +$14.6M 0.38% 99

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Palisade Capital Management's CDMO Position: Q4 2024 in Review

Palisade Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 1,962,999 shares — an estimated $22.3M sold.

Palisade Capital Management first reported a position in CDMO in Q1 2021 and held it in 15 quarters. The position peaked at $27.7M in Q4 2021. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Palisade Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Palisade Capital Management sold 1,962,999 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $22.3M.
  • Palisade Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 15 quarters.
  • Palisade Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $27.7M in Q4 2021.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Palisade Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.